ghk-cu peptide nasal spray Liquid | Research GHK-Cu Copper TriPeptide Nasal Spray

While not FDA-approved for specific indications, doctors can prescribe it as part of their medical practice for healing muscle, tendon, and ligament injuries

Key advantages include: Triple-peptide research formulation Ready-to-use laboratory format Reduced handling variability No mixing or reconstitution required Simplified experimental workflows Batch-to-batch consistency Professional laboratory packaging Designed exclusively for Research & Development The integrated pen system enables researchers to focus on experimental design while minimising preparation steps

FDA reportedly granted GRAS status for one specific oral formulation but not for the injectable peptide

Not approved for human use but no law specifically prohibits personal possession

Syringe units depend on the total vial strength, dilution amount, and desired peptide dose

Government of Western Australia